Healthcare & Medical Devices Global On demand · 24-48h

Global Objective Lameness Evaluation System Market Strategic Research Report

Global Objective Lameness Evaluation System Market Strategic…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Objective Lameness Evaluation System Market
$31.792025
9.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Portable System, Fixed System

By Application: Horse, Dog, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Equinosis LLC, Tekscan, Inc, Qualisys, 4Dvets AG, Sleip, Ekico, Equimoves, Vicon Motion Systems Ltd, TrojanTrack, Arioneo, Shanghai Xinsoft Information Technology Co., Ltd., Noldus

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 108 pages
Market size 2025
$31.79
Million USD
Forecast CAGR
9.3%
2025-2032
Forecast 2032
$59.2
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Objective Lameness Evaluation System market size is predicted to grow from US$ 31.79 million in 2025 to US$ 59.16 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032.

In 2025, the global production of objective lameness evaluation system is estimated at approximately 1,300 units, with an average selling price of approximately US$25,000 per unit, a gross profit margin of approximately 75%, and a single production line capacity of approximately 60 units per year. Objective lameness assessment systems significantly improve the accuracy, repeatability, and sensitivity of lameness diagnosis by digitizing and objectifying gait analysis, providing veterinarians with a powerful decision support tool and ultimately contributing to improved animal welfare and athletic performance. Objective lameness assessment systems utilize sensors, motion capture technology, and computer algorithms to quantify, analyze, and assess the gait of animals (primarily horses, but also including dogs and cattle) to detect and measure the degree of lameness. Their core principle is to replace subjective human judgment with objective, repeatable data, thereby providing more accurate and consistent diagnostic results. The upstream of objective lameness assessment systems mainly consists of core component and software suppliers (such as sensor chips and algorithm libraries), the midstream consists of system manufacturers that integrate technology and manufacture equipment, and the downstream consists of end-user channels for application and services (such as veterinary hospitals and racetracks). The demand stems fundamentally from the growing need for precision veterinary medicine downstream: driven by the need for downstream veterinary hospitals to improve diagnostic accuracy, the horse racing industry to pursue competitive performance and animal welfare, and research institutions to conduct in-depth biomechanical research. The ultimate goal is to achieve the objectification, quantification, management, and early intervention of animal lameness problems.

The growth of the global objective lameness evaluation system market is driven by four core factors: First, rising animal welfare awareness and regulatory pressure. Globally (especially in Europe and North America), increasingly stringent requirements for farm animal and racehorse welfare, coupled with retailers and regulatory bodies mandating quantifiable health documentation from producers, have made objective lameness assessment a key element of market access and brand reputation. Second, the growing popularity of precision veterinary medicine and early intervention concepts. Orthopedic veterinarians believe that early intervention can significantly improve lameness, while traditional subjective assessments struggle to detect subtle abnormalities. This has created an urgent need for quantifiable, highly sensitive diagnostic tools that establish individual animal gait baselines for early intervention. Third, the increasing intensification and economic benefits of animal husbandry. In large-scale farming, lameness directly leads to higher culling rates, decreased reproductive efficiency, and increased veterinary drug costs, prompting producers to actively seek automated, scalable monitoring systems to reduce economic losses. Finally, technological innovation and cost reduction. Advances in sensor technology (IMU), computer vision, and AI algorithms have made objective gait analysis systems more portable and user-friendly.

This report presents a comprehensive overview of the global Objective Lameness Evaluation System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Portable System
  • Fixed System

Segment by Technical Principles

  • Inertial Sensor-based System
  • Pressure Measurement-based System
  • Optical Motion Capture System
  • Computer Vision-based System

Segment by Measurement Environment

  • Controlled Environment System
  • Natural Environment System
  • Semi-Controlled Environment System

Segment by Application

  • Horse
  • Dog
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Objective Lameness Evaluation System market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Horse, Dog, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Objective Lameness Evaluation System Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$31.79
2025
Forecast
$59.2
2032
CAGR
9.3%
2025–2032
リージョン
5
global
Key companies
Equinosis LLCTekscan, IncQualisys4Dvets AGSleipEkicoEquimovesVicon Motion Systems Ltd
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Portable SystemFixed System
By Application
HorseDogOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Portable System
  • 3.1.3 Fixed System
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Horse
  • 4.1.3 Dog
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Equinosis LLC
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Tekscan, Inc
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Qualisys
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 4Dvets AG
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sleip
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Ekico
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Equimoves
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Vicon Motion Systems Ltd
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 TrojanTrack
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Arioneo
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shanghai Xinsoft Information Technology Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Noldus
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Objective Lameness Evaluation System market size?
The global Objective Lameness Evaluation System market is estimated at US$ 31.79 million in 2025 (base year) and is projected to reach US$ 59.16 million by 2032.
What growth rate is expected for the Objective Lameness Evaluation System market through 2032?
The market is expected to grow at a CAGR of 9.3% from 2026 to 2032, expanding from US$ 31.79 million in 2025 to US$ 59.16 million in 2032, roughly 1.9 times its base-year value.
How is Objective Lameness Evaluation System defined?
In 2025, the global production of objective lameness evaluation system is estimated at approximately 1,300 units, with an average selling price of approximately US$25,000 per unit, a gross profit margin of approximately 75%, and a single production line capacity of approximately 60 units per year. Objective lameness assessment systems utilize sensors, motion capture technology, and computer algorithms to quantify, analyze, and assess the gait of animals (primarily horses, but also including dogs and cattle) to detect and measure the degree of lameness.
How is the Objective Lameness Evaluation System market segmented by type?
By type, the market is segmented into Portable System and Fixed System.
What are the key applications of Objective Lameness Evaluation System?
Key applications covered include Horse, Dog and Other.
Which companies are profiled in the Objective Lameness Evaluation System market report?
Key players profiled include Equinosis LLC, Tekscan, Qualisys, 4Dvets AG, Sleip, Ekico, Equimoves and Vicon Motion Systems Ltd, among 12 companies covered in total.
What geographies does the Objective Lameness Evaluation System market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Objective Lameness Evaluation System?
The growth of the global objective lameness evaluation system market is driven by four core factors: First, rising animal welfare awareness and regulatory pressure.
Who should buy the Objective Lameness Evaluation System market report?
The report is intended for manufacturers and solution providers, distributors and end users in Horse, Dog and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Objective Lameness Evaluation System market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.